AUG 12, 2026 · PHASE 2 TRIAL
Personnalized Immunotherapy in Patients With Stage III Non-small Cell Lung Cancer
ClinicalTrials.gov
This is a Phase 2 interventional trial registration with no results posted; it describes a planned study of personalized immunotherapy selection based on MRD detection in stage III NSCLC, addressing an important clinical question but carrying no outcome data.
Reported
Planned enrollment177
PhasePhase 2
Primary outcome measureEfficacy of personalized consolidation immu…